Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents.
Hepatitis C virus (HCV) is transmitted between hepatocytes via classical cell entry but also uses direct cell-cell transfer to infect neighboring hepatocytes. Viral cell-cell transmission has been shown to play an important role in viral persistence allowing evasion from neutralizing antibodies. In...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3d82659e652242da9ba2435e2b6c3d43 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:3d82659e652242da9ba2435e2b6c3d43 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:3d82659e652242da9ba2435e2b6c3d432021-11-18T06:06:35ZHepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents.1553-73661553-737410.1371/journal.ppat.1004128https://doaj.org/article/3d82659e652242da9ba2435e2b6c3d432014-05-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24830295/pdf/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374Hepatitis C virus (HCV) is transmitted between hepatocytes via classical cell entry but also uses direct cell-cell transfer to infect neighboring hepatocytes. Viral cell-cell transmission has been shown to play an important role in viral persistence allowing evasion from neutralizing antibodies. In contrast, the role of HCV cell-cell transmission for antiviral resistance is unknown. Aiming to address this question we investigated the phenotype of HCV strains exhibiting resistance to direct-acting antivirals (DAAs) in state-of-the-art model systems for cell-cell transmission and spread. Using HCV genotype 2 as a model virus, we show that cell-cell transmission is the main route of viral spread of DAA-resistant HCV. Cell-cell transmission of DAA-resistant viruses results in viral persistence and thus hampers viral eradication. We also show that blocking cell-cell transmission using host-targeting entry inhibitors (HTEIs) was highly effective in inhibiting viral dissemination of resistant genotype 2 viruses. Combining HTEIs with DAAs prevented antiviral resistance and led to rapid elimination of the virus in cell culture model. In conclusion, our work provides evidence that cell-cell transmission plays an important role in dissemination and maintenance of resistant variants in cell culture models. Blocking virus cell-cell transmission prevents emergence of drug resistance in persistent viral infection including resistance to HCV DAAs.Fei XiaoIsabel FofanaLaura HeydmannHeidi BarthEric SoulierFrançois HabersetzerMichel DoffoëlJens BukhArvind H PatelMirjam B ZeiselThomas F BaumertPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 10, Iss 5, p e1004128 (2014) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5 |
spellingShingle |
Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5 Fei Xiao Isabel Fofana Laura Heydmann Heidi Barth Eric Soulier François Habersetzer Michel Doffoël Jens Bukh Arvind H Patel Mirjam B Zeisel Thomas F Baumert Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents. |
description |
Hepatitis C virus (HCV) is transmitted between hepatocytes via classical cell entry but also uses direct cell-cell transfer to infect neighboring hepatocytes. Viral cell-cell transmission has been shown to play an important role in viral persistence allowing evasion from neutralizing antibodies. In contrast, the role of HCV cell-cell transmission for antiviral resistance is unknown. Aiming to address this question we investigated the phenotype of HCV strains exhibiting resistance to direct-acting antivirals (DAAs) in state-of-the-art model systems for cell-cell transmission and spread. Using HCV genotype 2 as a model virus, we show that cell-cell transmission is the main route of viral spread of DAA-resistant HCV. Cell-cell transmission of DAA-resistant viruses results in viral persistence and thus hampers viral eradication. We also show that blocking cell-cell transmission using host-targeting entry inhibitors (HTEIs) was highly effective in inhibiting viral dissemination of resistant genotype 2 viruses. Combining HTEIs with DAAs prevented antiviral resistance and led to rapid elimination of the virus in cell culture model. In conclusion, our work provides evidence that cell-cell transmission plays an important role in dissemination and maintenance of resistant variants in cell culture models. Blocking virus cell-cell transmission prevents emergence of drug resistance in persistent viral infection including resistance to HCV DAAs. |
format |
article |
author |
Fei Xiao Isabel Fofana Laura Heydmann Heidi Barth Eric Soulier François Habersetzer Michel Doffoël Jens Bukh Arvind H Patel Mirjam B Zeisel Thomas F Baumert |
author_facet |
Fei Xiao Isabel Fofana Laura Heydmann Heidi Barth Eric Soulier François Habersetzer Michel Doffoël Jens Bukh Arvind H Patel Mirjam B Zeisel Thomas F Baumert |
author_sort |
Fei Xiao |
title |
Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents. |
title_short |
Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents. |
title_full |
Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents. |
title_fullStr |
Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents. |
title_full_unstemmed |
Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents. |
title_sort |
hepatitis c virus cell-cell transmission and resistance to direct-acting antiviral agents. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2014 |
url |
https://doaj.org/article/3d82659e652242da9ba2435e2b6c3d43 |
work_keys_str_mv |
AT feixiao hepatitiscviruscellcelltransmissionandresistancetodirectactingantiviralagents AT isabelfofana hepatitiscviruscellcelltransmissionandresistancetodirectactingantiviralagents AT lauraheydmann hepatitiscviruscellcelltransmissionandresistancetodirectactingantiviralagents AT heidibarth hepatitiscviruscellcelltransmissionandresistancetodirectactingantiviralagents AT ericsoulier hepatitiscviruscellcelltransmissionandresistancetodirectactingantiviralagents AT francoishabersetzer hepatitiscviruscellcelltransmissionandresistancetodirectactingantiviralagents AT micheldoffoel hepatitiscviruscellcelltransmissionandresistancetodirectactingantiviralagents AT jensbukh hepatitiscviruscellcelltransmissionandresistancetodirectactingantiviralagents AT arvindhpatel hepatitiscviruscellcelltransmissionandresistancetodirectactingantiviralagents AT mirjambzeisel hepatitiscviruscellcelltransmissionandresistancetodirectactingantiviralagents AT thomasfbaumert hepatitiscviruscellcelltransmissionandresistancetodirectactingantiviralagents |
_version_ |
1718424530494423040 |